Home monitoring: prognosis, benefits and pitfalls

M. Wijsenbeek (Rotterdam, Netherlands)

Source: Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wijsenbeek (Rotterdam, Netherlands). Home monitoring: prognosis, benefits and pitfalls. Virtual Congress 2021 – Holistic care in interstitial lung disease: monitoring the patient’s pathway

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oxygen at home: benefits, practical implications and pitfalls
Source: Annual Congress 2012 - Primary Care Programme
Year: 2012


Clinical applications of electronic monitoring - potential and pitfalls
Source: Annual Congress 2005 - Practical and scientific considerations in the use of new electronic technologies for ambulatory monitoring of respiratory disease
Year: 2005

Health outcomes assessment and economic evaluation in COPD: challenges and opportunities
Source: Eur Respir J 2003; 21: 1S-3S
Year: 2003


Physician perspectives: monitoring severe AATD and optimising treatment
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017


Implementing local guidelines: the potential for cost savings and improvement of patient care
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006

Telehealth possibilities and pitfalls in COVID-19 lockdown: a case of hypoxia in a child
Source: Virtual Congress 2021 – CCC Paediatric respiratory diseases
Year: 2021


Individualised staging: practical implications
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Practical considerations: comorbidities, pitfalls and individual cases
Source: International Congress 2019 – Guidelines for long-term non-invasive ventilation in chronic obstructive pulmonary disease
Year: 2019


What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement
Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018
Year: 2018



Common pitfalls in the assessment of airway disease in primary care
Source: Annual Congress 2009 - Controversies in the diagnosis of asthma
Year: 2009


Applicability of pulmonary rehabilitation in primary care: critical success factors, use of patient reported outcomes and consequences of population differences
Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care
Year: 2011


Prescription opioid use in advanced COPD: benefits, perils and controversies
Source: Eur Respir J, 49 (6) 1700479; 10.1183/13993003.00479-2017
Year: 2017



Prescription opioid use in advanced COPD: benefits, perils and controversies
Source: Eur Respir J, 49 (6) 1700690; 10.1183/13993003.00690-2017
Year: 2017



Lung function testing in the COVID era: safety concerns you should consider
Source: COVID-19 Videos
Year: 2020

COPD: implementing biomarkers to improve prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021


Interoperability in healthcare: benefits and challenges
Source: International Congress 2016 – Implementation of collaborative lung function testing
Year: 2016


Acceptance criteria for intensive care: we need new definitions and legislations for futile treatment!
Source: International Congress 2017 – COPD and weaning
Year: 2017


Adapting local practices can increase compliance and hence outcome of pulmonary rehabilitation (PR) in resource limited settings
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Suboptimal asthma control: prevalence, detection and consequences in general practice
Source: Eur Respir J 2008; 31: 320-325
Year: 2008